Funding
← Back to your selection

Leaps by Bayer

Activity from announced rounds

Activity in this selectionOct 17, 2026 · Sep 18, 2026

Leaps by Bayer is the venture investment organization whose official news identifies Robigo and Sabanto.

Recorded funding activity

Robigo develops microbial crop protection. Sabanto retrofits agricultural equipment for autonomous operation, while Celea develops respiratory medicines. These company relationships belong to the Leaps organization separately from the Bayer parent.

Sources
Rounds participated in
2
Confirmed lead rounds
1
All roles disclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$135M
1 disclosed · full round size, not this investor’s share

By stage

Series A1
Series B1

By primary sector

Agritech1
Biotech1

By country

United States2

Rounds

2 in this selection
Soufflé Therapeutics

Soufflé Therapeutics develops targeted RNA medicines for patients with muscle disorders and heart failure.

$135MSeries B
Participant
Robigo

Robigo engineers biological crop-protection solutions that use targeted microbes to control plant pathogens while preserving beneficial organisms.

UndisclosedSeries A
Lead